IBM Retirement Fund’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,062
| Closed | -$1.06M | – | 456 |
|
|
2022
Q1 | $1.06M | Sell |
4,062
-250
| -6% | -$59.3K | 0.15% | 121 |
|
|
2021
Q4 | $947K | Sell |
4,312
-3,022
| -41% | -$588K | 0.12% | 150 |
|
|
2021
Q3 | $1.33M | Buy |
7,334
+27
| +0.4% | +$5.27K | 0.1% | 166 |
|
|
2021
Q2 | $1.47M | Sell |
7,307
-1,538
| -17% | -$322K | 0.12% | 154 |
|
|
2021
Q1 | $1.9M | Sell |
8,845
-797
| -8% | -$175K | 0.13% | 134 |
|
|
2020
Q4 | $2.28M | Buy |
9,642
+577
| +6% | +$132K | 0.16% | 121 |
|
|
2020
Q3 | $2.47M | Buy |
9,065
+2,374
| +35% | +$655K | 0.21% | 84 |
|
|
2020
Q2 | $1.94M | Sell |
6,691
-17
| -0.3% | -$4.61K | 0.25% | 74 |
|
|
2020
Q1 | $1.6M | Buy |
6,708
+2,303
| +52% | +$528K | 0.29% | 77 |
|
|
2019
Q4 | $964K | Sell |
4,405
-150
| -3% | -$30.4K | 0.17% | 106 |
|
|
2019
Q3 | $772K | Sell |
4,555
-48
| -1% | -$8.49K | 0.15% | 131 |
|
|
2019
Q2 | $844K | Buy |
4,603
+78
| +2% | +$13.6K | 0.16% | 113 |
|
|
2019
Q1 | $832K | Buy |
4,525
+28
| +0.6% | +$5.17K | 0.16% | 112 |
|
|
2018
Q4 | $745K | Sell |
4,497
-298
| -6% | -$51.6K | 0.17% | 109 |
|
|
2018
Q3 | $924K | Sell |
4,795
-716
| -13% | -$127K | 0.21% | 111 |
|
|
2018
Q2 | $937K | Sell |
5,511
-658
| -11% | -$102K | 0.2% | 123 |
|
|
2018
Q1 | $1M | Sell |
6,169
-130
| -2% | -$21.2K | 0.19% | 128 |
|
|
2017
Q4 | $1.04M | Buy |
6,299
+59
| +0.9% | +$8.74K | 0.18% | 146 |
|
|
2017
Q3 | $1.04M | Buy |
6,240
+135
| +2% | +$20.3K | 0.19% | 138 |
|
|
2017
Q2 | $879K | Buy |
6,105
+3,355
| +122% | +$404K | 0.16% | 162 |
|
|
2017
Q1 | $401K | Sell |
2,750
-20,408
| -88% | -$1.8M | 0.11% | 187 |
|
|
2016
Q4 | $1.79M | Sell |
23,158
-138
| -0.6% | -$11.2K | 0.08% | 256 |
|
|
2016
Q3 | $2.03M | Sell |
23,296
-8,936
| -28% | -$844K | 0.1% | 219 |
|
|
2016
Q2 | $2.86M | Buy |
32,232
+449
| +1% | +$38.8K | 0.1% | 219 |
|
|
2016
Q1 | $2.59M | Sell |
31,783
-28,137
| -47% | -$2.55M | 0.1% | 228 |
|
|
2015
Q4 | $7.54M | Buy |
59,920
+574
| +1% | +$69.3K | 0.14% | 148 |
|
|
2015
Q3 | $6.3M | Sell |
59,346
-153
| -0.3% | -$19.7K | 0.13% | 165 |
|
|
2015
Q2 | $7.35M | Buy |
59,499
+1,308
| +2% | +$165K | 0.14% | 152 |
|
|
2015
Q1 | $6.87M | Sell |
58,191
-72
| -0.1% | -$8.63K | 0.13% | 174 |
|
|
2014
Q4 | $6.92M | Sell |
58,263
-273
| -0.5% | -$30.7K | 0.13% | 169 |
|
|
2014
Q3 | $6.58M | Sell |
58,536
-1,789
| -3% | -$170K | 0.13% | 168 |
|
|
2014
Q2 | $5.68M | Buy |
60,325
+194
| +0.3% | +$13.6K | 0.11% | 200 |
|
|
2014
Q1 | $4.24M | Sell |
60,131
-33,100
| -36% | -$2.62M | 0.08% | 249 |
|
|
2013
Q4 | $6.93M | Sell |
93,231
-3,730
| -4% | -$260K | 0.09% | 226 |
|
|
2013
Q3 | $7.35M | Sell |
96,961
-8,217
| -8% | -$654K | 0.1% | 214 |
|
|
2013
Q2 | $8.4M | Buy |
+105,178
| New | +$7.75M | 0.1% | 206 |
|
Other funds holding VRTX
IBM Retirement Fund's VRTX Position: Q2 2022 in Review
IBM Retirement Fund sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 4,062 shares — an estimated $1.06M sold.
IBM Retirement Fund first reported a position in VRTX in Q2 2013 and held it in 36 quarters. The position peaked at $8.4M in Q2 2013. 1,106 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.
- IBM Retirement Fund reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- IBM Retirement Fund sold 4,062 Vertex Pharmaceuticals shares in Q2 2022, an estimated $1.06M.
- IBM Retirement Fund first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 36 quarters.
- IBM Retirement Fund's Vertex Pharmaceuticals position peaked at $8.4M in Q2 2013.
- 1,106 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.
Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.